Mejias, Nancy H.
Martinez, Camila C.
Stephens, Marisa E.
de Rivero Vaccari, Juan Pablo http://orcid.org/0000-0002-5460-8834
Article History
Received: 27 June 2018
Accepted: 5 November 2018
First Online: 16 November 2018
Ethics approval and consent to participate
: Subjects were enrolled in the study Prospective Collection of Samples for Research according to an IRB approved by Schulman Associates IRB for Bioreclamation<i>IVT</i>. Samples used in this study were purchased from Bioreclamation<i>IVT</i>.
: Not applicable.
: JPdRV has patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.